Jane Street’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
Other funds holding VTGN
Jane Street's VTGN Position: Q3 2026 in Review
Jane Street increased its VistaGen Therapeutics (VTGN) stake by 223% in Q3 2026, buying an estimated $93K and bringing the position to 532,276 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #10229.
Jane Street first reported a position in VTGN in Q1 2019 and has held it in 14 quarters since. The position peaked at $1.07M in Q3 2025. 42 funds tracked by Wall St. Rank hold VTGN as of Q3 2026.
- Jane Street held 532,276 shares of VistaGen Therapeutics worth $164K as of Q3 2026.
- Jane Street bought 367,449 VistaGen Therapeutics shares in Q3 2026, an estimated $93K.
- VistaGen Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #10229 holding.
- Jane Street first reported a position in VistaGen Therapeutics in Q1 2019 and has held it in 14 quarters since.
- Jane Street's VistaGen Therapeutics position peaked at $1.07M in Q3 2025.
- 42 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.